ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,447Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 24

$672K Total Retail Price of All Prescriptions

Rank: 6 out of 24

636 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 10,990 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 602 540 1 5
LISINOPRIL 512 459 2 4
AMLODIPINE BESYLATE 504 457 3 2
OMEPRAZOLE 485 412 4 8
LEVOTHYROXINE SODIUM 406 368 5 1
ATORVASTATIN CALCIUM 320 296 6 21
FUROSEMIDE 318 303 7 3
HYDROCHLOROTHIAZIDE 275 247 8 23
METFORMIN HCL 245 208 9 19
METOPROLOL SUCCINATE 226 214 10 27
METOPROLOL TARTRATE 223 200 11 7
CITALOPRAM HBR 221 172 12 12
ZOLPIDEM TARTRATE 220 216 13 32
DONEPEZIL HCL 202 195 14 16
WARFARIN SODIUM 199 191 15 11
PRAVASTATIN SODIUM 198 177 16 22
CRESTOR 193 177 17 79
HYDROCODONE-ACETAMINOPHEN 183 120 S3 18 6
GABAPENTIN 166 144 19 13
SERTRALINE HCL 140 118 20 18
CARVEDILOL 140 125 20 24
METFORMIN HCL ER 140 131 20 150
LOSARTAN-HYDROCHLOROTHIAZIDE 139 135 23 124
ATENOLOL 138 121 24 30
LOSARTAN POTASSIUM 136 131 25 29
NEXIUM 134 108 26 38
POTASSIUM CHLORIDE 127 118 27 15
RANITIDINE HCL 116 102 28 36
GLIPIZIDE ER 108 94 29 106
PREDNISONE 103 95 30 28
MELOXICAM 102 85 31 97
TRAMADOL HCL 99 82 32 25
DIOVAN 92 76 33 39
CLOPIDOGREL 91 87 34 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 68 35 178
TRICOR 90 90 35 178
AZITHROMYCIN 88 76 37 94
DIGOXIN 82 74 38 44
NAMENDA 82 82 38 9
QUINAPRIL HCL 71 50 40 189
PLAVIX 69 67 41 65
ESCITALOPRAM OXALATE 65 58 42 17
CLONIDINE HCL 64 62 43 83
BENICAR 63 52 44 198
ISOSORBIDE MONONITRATE ER 62 58 45 46
AMLODIPINE BESYLATE-BENAZEPRIL 61 52 46 134
KLOR-CON M20 60 57 47 55
ADVAIR DISKUS 57 56 48 62
GLIPIZIDE XL 57 48 48 209
GLIMEPIRIDE 56 46 50 163
PREMARIN 55 42 R 51 160
PANTOPRAZOLE SODIUM 55 47 51 52
GEMFIBROZIL 53 44 53 168
AMOXICILLIN 52 47 54 219
DILTIAZEM ER 50 50 55 166
ALENDRONATE SODIUM 50 50 55 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.